Your session is about to expire
← Back to Search
HMB + Amino Acids for Liver Cirrhosis
Study Summary
This trial is testing whether or not leucine can help to improve the muscle mass of cirrhotic patients by stimulating protein synthesis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread to other parts of my body.I have been diagnosed with severe brain function problems.I have been diagnosed with cirrhosis of the liver.I am on dialysis for kidney failure.I do not have severe heart, lung, or kidney disease.My liver function is moderately impaired.I currently have an infection.I am not taking any medications that affect blood clotting.I have swelling in my feet.I recently had surgery on my intestines or stomach.I have not had any bleeding in my stomach or intestines in the last 3 months.I am not taking any medications that affect muscle growth or breakdown.
- Group 1: Hydroxy Methyl Butyrate
- Group 2: Balanced Amino Acid Mixture
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I meet the requirements to participate in this experiment?
"This experiment is seeking 24 individuals with liver cirrhosis between the ages of 21 and 65; they must also have a Child-Pugh score ranging from 5 to 8."
Are there any current open recruitment initiatives related to this experiment?
"Reportedly, this investigation is still enrolling participants. The protocol was first uploaded to clinicaltrials.gov on November 30th 2021 and the data were updated as recently as October 19th 2022."
Does this research endeavor allow persons under 35 years old to participate?
"Patients that are eligible to participate in this medical study must be between 21 and 65 years of age. For those who fall outside of this range, 76 trials exist for people under 18 while 429 studies cover individuals above the retirement-age threshold."
How many participants have successfully enrolled in this research project?
"Affirmative. Current records hosted on clinicaltrials.gov suggest that this medical trial, which was launched on November 30th 2021, is currently recruiting patients. A total of 24 participants are needed for the study taking place at a single location."
Share this study with friends
Copy Link
Messenger